The abstract is read at the publisher; the summary is JClub's.
In CoCl2-treated HeLa cells, STL1267 reshapes hypoxia-associated transcription by altering HIF-1α and REV-ERBα localization and changing expression of 132 genes (FDR < 0.05).
- Why it matters: REV-ERB regulates metabolism, but how its agonists affect cellular adaptation to hypoxia-linked stress—especially via protein compartmentalization and gene programs—remains unclear.
- What they did: HeLa cells were treated with vehicle, CoCl2 plus vehicle, or CoCl2 plus STL1267; immunofluorescence tracked HIF-1α/REV-ERBα distribution and RNA sequencing quantified gene changes. CoCl2 altered 267 genes, while STL1267 during CoCl2 altered 132 genes (FDR < 0.05), including increased ATF4 and amino-acid/one-carbon metabolism genes such as ASNS, PHGDH, PSAT1, PSPH, and MTHFD2.
- The result: STL1267 reduced nuclear HIF-1 staining relative to CoCl2 and increased extranuclear REV-ERB staining, while it decreased CoCl2-induced CA9, BNIP3, and LDHA without significant changes in HK2, PDK1, or VEGFA. This implies REV-ERB ligand treatment can selectively tune hypoxia-linked metabolic stress responses in this cell model.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.